Liangqing Yao

710 total citations
38 papers, 442 citations indexed

About

Liangqing Yao is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Liangqing Yao has authored 38 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Reproductive Medicine, 12 papers in Oncology and 12 papers in Obstetrics and Gynecology. Recurrent topics in Liangqing Yao's work include Ovarian cancer diagnosis and treatment (15 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Cancer-related molecular mechanisms research (6 papers). Liangqing Yao is often cited by papers focused on Ovarian cancer diagnosis and treatment (15 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Cancer-related molecular mechanisms research (6 papers). Liangqing Yao collaborates with scholars based in China, France and United States. Liangqing Yao's co-authors include Jie Wu, Mo Chen, Danqing Zheng, Yong Luo, Xiaolin Pan, Chen Chen, Xiuling Zhi, Dan Meng, Jieyu Guo and Lei Yuan and has published in prestigious journals such as Journal of Clinical Oncology, Chemical Communications and Frontiers in Immunology.

In The Last Decade

Liangqing Yao

34 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangqing Yao China 11 140 124 79 79 71 38 442
Amelia Paglia Italy 9 25 0.2× 144 1.2× 129 1.6× 103 1.3× 64 0.9× 10 456
Qing-Xiang Amy Sang United States 9 44 0.3× 164 1.3× 155 2.0× 12 0.2× 178 2.5× 10 386
Mariangela Zanghì Italy 7 34 0.2× 144 1.2× 234 3.0× 29 0.4× 79 1.1× 12 414
Dan Chan United States 6 24 0.2× 250 2.0× 287 3.6× 55 0.7× 84 1.2× 13 532
Kirsty Ratcliffe United Kingdom 6 20 0.1× 243 2.0× 123 1.6× 29 0.4× 77 1.1× 7 385
Huiyu Zhuang China 13 12 0.1× 237 1.9× 75 0.9× 146 1.8× 130 1.8× 21 436
Arpita Desai United States 10 11 0.1× 229 1.8× 165 2.1× 62 0.8× 116 1.6× 38 451
Simona Duranti Italy 12 11 0.1× 114 0.9× 236 3.0× 35 0.4× 102 1.4× 28 449
Ben Staal United States 9 22 0.2× 219 1.8× 140 1.8× 9 0.1× 61 0.9× 14 365
Dianne Spillman United States 6 14 0.1× 144 1.2× 179 2.3× 14 0.2× 62 0.9× 8 387

Countries citing papers authored by Liangqing Yao

Since Specialization
Citations

This map shows the geographic impact of Liangqing Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangqing Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangqing Yao more than expected).

Fields of papers citing papers by Liangqing Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangqing Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangqing Yao. The network helps show where Liangqing Yao may publish in the future.

Co-authorship network of co-authors of Liangqing Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Liangqing Yao. A scholar is included among the top collaborators of Liangqing Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangqing Yao. Liangqing Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiajia, Yihua Sun, Xiuling Zhi, et al.. (2024). Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1. Journal of Ovarian Research. 17(1). 61–61. 4 indexed citations
2.
Li, Jiajia, et al.. (2024). Proteome-Wide Mendelian Randomization Analysis to Identify Potential Plasma Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer Subtypes. International Journal of Women s Health. Volume 16. 2263–2279. 1 indexed citations
3.
Li, Jiajia, et al.. (2024). Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems. International Journal of Nanomedicine. Volume 19. 9351–9370. 5 indexed citations
4.
Mo, Jiahang, et al.. (2024). CD47—a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features. World Journal of Surgical Oncology. 22(1). 44–44. 3 indexed citations
5.
6.
Yao, Liangqing, et al.. (2023). Do ethnic chinese older adults with epithelial ovarian cancer survive a poorer prognosis?. Journal of Ovarian Research. 16(1). 110–110. 2 indexed citations
7.
Chen, Mo, et al.. (2023). Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer. World Journal of Surgical Oncology. 21(1). 375–375. 5 indexed citations
8.
Zhang, Hao, et al.. (2023). Novel predictors for identifying cervical minimal deviation adenocarcinoma patients with poor prognosis: a long-term observational study in a tertiary centre. Archives of Gynecology and Obstetrics. 309(4). 1483–1490. 1 indexed citations
9.
Yuan, Lei, et al.. (2023). A Vascular Centered Surgical Approach to Radical Hysterectomy: Laparoscopic Anatomy of Pelvic Vascular System Revisited. Journal of Minimally Invasive Gynecology. 30(9). 692–692.
10.
11.
Zhao, Yaqian, Shanshan Cheng, Nan Zhang, et al.. (2022). Artificial intelligence-based preoperative prediction system for diagnosis and prognosis in epithelial ovarian cancer: A multicenter study. Frontiers in Oncology. 12. 975703–975703. 18 indexed citations
12.
Zhi, Xiuling, et al.. (2022). The PDGF Family Is Associated with Activated Tumor Stroma and Poor Prognosis in Ovarian Cancer. Disease Markers. 2022. 1–19. 12 indexed citations
13.
14.
15.
Gao, Tong, Mingming Sun, Liangqing Yao, & Wei Jiang. (2018). False diagnosis of and needless therapy for presumed gestational trophoblastic disease in women with an unusual site of residual pregnancy. Journal of International Medical Research. 47(2). 673–681. 2 indexed citations
16.
Jia, Nan, et al.. (2018). Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer. International Journal of Gynecological Cancer. 28(9). 1812–1820. 10 indexed citations
17.
Gao, Tong, Yi Yu, Qing Cong, et al.. (2018). Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor. BMC Cancer. 18(1). 999–999. 25 indexed citations
18.
Li, Na, Yuanyuan Chu, Liangqing Yao, et al.. (2011). A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency. Journal of Cancer Research and Clinical Oncology. 137(10). 1455–1461. 1 indexed citations
19.
Yi, Xiaofang, Jingxin Ding, Weiwei Feng, et al.. (2011). [Comparison outcomes of three surgical procedures in treatment of severe pelvic organ prolapse and analysis of risk factors for genital prolapse recurrence].. PubMed. 46(2). 94–100. 3 indexed citations
20.
Yao, Liangqing, et al.. (2006). Characterization of unilateral polycystic ovary compared with polycystic ovary syndrome. Fertility and Sterility. 85(3). 805–808. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amelia Paglia Breakdown of academic impact, for papers by Qing-Xiang Amy Sang Breakdown of academic impact, for papers by Mariangela Zanghì Breakdown of academic impact, for papers by Dan Chan Breakdown of academic impact, for papers by Kirsty Ratcliffe Breakdown of academic impact, for papers by Huiyu Zhuang Breakdown of academic impact, for papers by Arpita Desai Breakdown of academic impact, for papers by Simona Duranti Breakdown of academic impact, for papers by Ben Staal Breakdown of academic impact, for papers by Dianne Spillman
Rankless by CCL
2026